Admission Date:  [**2186-2-20**]       Discharge Date:  [**2186-2-25**]  Date of Birth:   [**2109-4-21**]       Sex:  M  Service:  HISTORY OF THE PRESENT ILLNESS:  This is a 76-year-old gentleman who is status post radiation therapy to his larynx for squamous cell carcinoma of the glottis.
He completed radiation therapy in [**2185-1-28**].
The patient subsequently had undergone a left vocal fold cordotomy with negative margins.
The patient discussed the options for surgical therapy with Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] and agreed after discussing the risks and benefits to undergo a total laryngectomy.
HOSPITAL COURSE:  The patient underwent a total laryngectomy with Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] on [**2186-2-20**].
Cardiac: The patient was stable on Verapamil and pneumoboots for DVT prophylaxis.
with a G tube and Lansoprazole for GI prophylaxis.
Genitourinary:  The patient had a Foley which was making adequate urine and the creatinine was 0.8.
Infectious disease:  The patient was on Ancef and Flagyl.
Fluids, electrolytes, and nutrition:  The patient was on D5 half normal saline at 100 cc per hour and was maintained n.p.o.
Over the course of the next several days, the patient tolerated his hospitalization well.
Cardiac:  He remained on his cardiac medications, verapamil 80 mg q. eight hours p.o.
Tube feeding was performed through the gastrostomy tube of Promote full-strength with fiber, initial rate of 10 cc per hour, increasing 10 cc every four hours with an end goal rate of 75 cc per hour.
The patient tolerated his tube feeds well with the exception of the night prior to discharge to rehabilitation.
The patient developed some mild distention and his tube feeds were placed on hold with the intention of restarting them when the distention cleared and the residuals were less than 100 cc q. four hours.
Foley catheter in place.
Infectious disease:  The patient is to remain on Ancef and Flagyl intravenously, Ancef 1 gram IV q. eight hours until [**2186-2-27**] and then end, Flagyl 500 mg IV t.i.d.
until [**2186-2-27**] and then end, starting on [**2186-2-27**], Augmentin 500 mg per G tube t.i.d.
Lasix 40 mg p.o.
Lansoprazole 30 mg p.o.
Spironolactone 50 mg p.o.
Tylenol elixir 325-650 mg q. four hours to q. six hours p.r.n.
Heparin 5,000 units subcutaneously b.i.d.
Zofran 2-4 mg IV q. six hours p.r.n.
Roxicet [**4-8**] ml p.o.
Verapamil 80 mg q. eight hours p.o.
Flagyl 500 mg IV q. eight hours, end date [**2186-2-27**].
Ancef 1 gram IV q. eight hours, end date [**2186-2-27**].
Neutra-Phos one packet t.i.d.
Docusate 100 mg p.o.
Augmentin 500 mg per G tube q. eight hours, start date [**2186-2-27**], end date [**2186-3-6**].
The patient is on tube feeds of Promote with fiber, full-strength, starting at 10 cc per hour, advance 10 cc q. four hours with the goal of 75 cc, hold for distention, nausea, or residuals greater than 100 cc q. four hours.
